Investigator's Brochure (IB) Table

Drugs

Drug Name Drug Company IB Date Risk List Available?
Tenofovir Alafenamide/Elvitegravir CONRAD July 2019
Glecaprevir (ABT-493) and Pibrentasvir (ABT-530) AbbVie December 2018
Cemiplimab (REGN2810) Regeneron Pharmaceuticals, Inc. May 2019
Tenofovir Vaginal Ring CONRAD August 2017
Sofosbuvir/Velapatasvir (Epclusa) Gilead July 2016
PC-1005 Population Council April 2017
Vorinostat (Zolinza) Merck August 2013
Doravirine (MK-1439) Merck May 2019
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) Merck May 2019
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences December 2016 YES
Etravirine (TMC125, Intelence) - New Janssen Research & Development November 2019
GSK1265744 (Cabotegravir) ViiV Healthcare December 2018
HEC Placebo Gel CONRAD September 2011
Maraviroc (UK-427857) ViiV Healthcare October 2017
Raltegravir (Isentress) Merck September 2017 YES
Rifapentine Sanofi August 2013
Rilpivirine (TMC278, Edurant) Janssen Research & Development July 2019
ABT-267, ABT 333, ABT-450 and Ritonavir AbbVie June 2017
Tenofovir Gel CONRAD January 2013
Bedaquiline (TMC207) Janssen Research & Development February 2019

Vaccines

Vaccine Name Vaccine Company Sort descending IB Date Risk List Available?
PGT121 Beth Israel Deaconess Medical Center January 2019
PGDM1400 Beth Israel Deaconess Medical Center August 2018
Ad26.ENVA.01 Crucell Holland BV June 2013
MPER-656 Liposomes with Aluminum Hydroxide Suspension DAIDS/NIAID/NIH February 2019
B63521^11 gp120 DAIDS/NIAID/NIH July 2019
DNA CON-S env DAIDS/NIAID/NIH June 2017
BG505 SOSIP.664 gp140 - New DAIDS/NIAID/NIH October 2019
DNA Mosaic-Tre env DNA Vaccine DAIDS/NIAID/NIH July 2016
EnvSeq-1 Vaccine (CH505TF gp120) DAIDS/NIAID/NIH August 2019
CH505TF gp120 Transient DAIDS/NIAID/NIH December 2018
Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) - New Dynavax Technologies Corporation August 2019
GEO-D03 and MVA-HIV62B Vaccines (Preventative) GeoVax June 2013
GEO-D02 and MVA-HIV62B Vaccine GeoVax June 2019
Bivalent Subtype C gp120/AS01B GlaxoSmithKline July 2016
Bivalent Subtype C gp120/MF59 GlaxoSmithKline July 2016
AIDSVAX B/E Global Solutions for Infectious Diseases March 2016
GLA-SE Infectious Disease Research Institute (IDRI) April 2019
PENNVAX-GP and IL-12 DNA Inovio Parmaceuticals December 2016
DNA-HIV-PT123 IPPOX January 2019
DNA-HIV-PT123/NYVAC-HIV-PT1/NYVAC-HIV-PT4 vaccine IPPOX/EuroVacc August 2013